Skip to main navigation Skip to search Skip to main content

Simvastatin reduces wasting and improves cardiac function as well as outcome in experimental cancer cachexia

  • Sandra Palus
  • , Stephan von Haehling
  • , Valerie C Flach
  • , Anika Tschirner
  • , Wolfram Doehner
  • , Stefan D Anker
  • , Jochen Springer

Research output: Contribution to journalArticlepeer-review

47 Citations (Scopus)

Abstract

Chronic inflammation is common in cancer cachexia (CC) and directly involved in the atrophy seen in this condition. Recently, several groups have described a form of cardiomyopathy in CC animal models. Hence, we investigated the effect of simvastatin with its known anti-inflammatory and cardioprotective effects in a rat model of CC.
Original languageEnglish
Pages (from-to)3412-8
Number of pages7
JournalInternational Journal of Cardiology
Volume168
Issue number4
DOIs
Publication statusPublished - 9 Oct 2013

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Cite this